ScholarIQanswers from OpenAlex & ORCID
Thomas M. O’Dorisio
ResearcherPublications, citations & collaboration network
Thomas M. O’Dorisio is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas M. O’Dorisio have?
ScholarIQindexed works
Thomas M. O’Dorisio has 516 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas M. O’Dorisio have?
ScholarIQcitation count
Thomas M. O’Dorisio has 19,113 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas M. O’Dorisio?
ScholarIQh-index
Thomas M. O’Dorisio has an h-index of 66 in OpenAlex.
What is the i10-index of Thomas M. O’Dorisio?
ScholarIQi10-index
Thomas M. O’Dorisio has an i10-index of 286 in OpenAlex.
What is the ORCID of Thomas M. O’Dorisio?
ScholarIQorcid
The ORCID for Thomas M. O’Dorisio is on the source record.
What is the OpenAlex record for Thomas M. O’Dorisio?
ScholarIQopenalex
The OpenAlex for Thomas M. O’Dorisio is on the source record.
What are the most-cited papers on Thomas M. O’Dorisio?
ScholarIQmost cited works
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
James C. Yao, Catherine Lombard‐Bohas, Éric Baudin, Larry K. Kvols, Philippe Rougier, Philippe Ruszniewski, Sakina Hoosen, J. Peter, T Haas, David Lebwohl, Eric Van Cutsem, Matthew H. Kulke, Timothy J. Hobday, Thomas M. O’Dorisio, Manisha H. Shah, Guillaume Cadiot, Gabriele Luppi, James Posey, Bertram Wiedenmann
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Dik J. Kwekkeboom, Jan Mueller‐Brand, Giovanni Paganelli, Lowell Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maëcke, Eric P. Krenning
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
Jonathan Strosberg, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, Jennifer A. Chan, Joseph S. Dillon, Anthony P. Heaney, Pamela L. Kunz, Thomas M. O’Dorisio, Riad Salem, Eva Segelov, James R. Howe, Rodney F. Pommier, Kari Brendtro, Mohammad Bashir, Simron Singh, Michael C. Soulen, Laura Tang, Jerome Zacks, James C. Yao, Emily K. Bergsland
The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs)
Lowell Anthony, Jonathan Strosberg, David S. Klimstra, William J. Maples, Thomas M. O’Dorisio, Richard R.P. Warner, Gregory A. Wiseman, Al B. Benson, Rodney F. Pommier